# LyondellBasell Industries N.V. (LYB) â€“ Financial Analysis (November 2025)

**Analysis Date:** November 3, 2025  
**Data Period:** Q3 2025 Results and TTM Financials  
**Analyst:** Investment Analysis Framework

---

## Executive Summary

**BLUF: LYB navigates a severe cyclical downturn with Q3 2025 EBITDA of $835M excluding $1.2B in asset write-downs, generating strong cash conversion of 135% and maintaining $6.5B liquidity. The company is executing a disciplined Cash Improvement Plan targeting $600M incremental cash flow in 2025 and $1.1B by end of 2026, while strategically repositioning its portfolio through European asset sales and cost-advantaged region focus. Current valuation at 0.41x Price/Sales reflects deep cyclical trough; company maintains investment-grade balance sheet but faces near-term margin pressure. Recommendation: Hold for value investors - strong positioning for cycle recovery but near-term headwinds remain.**

LyondellBasell reported challenging Q3 2025 results amid the longest downturn in management's 35-year industry experience. The company reported a net loss of $(890) million, driven largely by $1.2 billion in non-cash asset write-downs related to goodwill impairments and portfolio repositioning. Excluding identified items, net income was $330 million with EBITDA of $835 million, demonstrating operational resilience despite difficult market conditions. Cash generation remained strong with $983 million from operating activities and 135% cash conversion, highlighting the company's ability to convert earnings to cash even in challenging times.

---

## Key Financial Metrics

### Revenue Performance
| Metric                        | Q3 2025   | Q2 2025   | Q3 2024   | TTM         | 12/31/2024  | 12/31/2023  |
|-------------------------------|-----------|-----------|-----------|-------------|-------------|-------------|
| **Total Revenue**             | $7,727M   | $7,658M   | $8,604M   | $38,655M    | $40,302M    | $41,107M    |
| Revenue Growth (YoY)          | -10.2%    | --        | --        | -4.1%       | -2.0%       | -18.1%      |
| Revenue Growth (QoQ)          | +0.9%     | --        | --        | --          | --          | --          |

### Profitability Analysis
| Metric                        | Q3 2025   | Q2 2025   | Q3 2024   | TTM         | 12/31/2024  | 12/31/2023  |
|-------------------------------|-----------|-----------|-----------|-------------|-------------|-------------|
| **Net Income (GAAP)**         | $(890)M   | $115M     | $573M     | $248M       | $1,353M     | $2,107M     |
| **Net Income (Ex. Items)**    | $330M     | $202M     | $626M     | $642M       | $1,353M     | $2,107M     |
| **EBITDA (GAAP)**             | $(480)M   | $606M     | $1,170M   | $781M       | $3,606M     | $4,638M     |
| **EBITDA (Ex. Items)**        | $835M     | $715M     | $1,205M   | $2,126M     | $3,606M     | $4,638M     |
| **Operating Income**          | $1,547M   | --        | --        | $1,547M     | $2,766M     | $3,571M     |
| **Gross Profit**              | $3,362M   | --        | --        | $3,362M     | $4,564M     | $5,258M     |
| **Gross Margin**              | 8.7%      | --        | --        | 8.7%        | 11.3%       | 12.8%       |
| **Operating Margin**          | 4.0%      | --        | --        | 4.0%        | 6.9%        | 8.7%        |
| **EBITDA Margin (Ex. Items)** | 10.8%     | 9.3%      | 14.0%     | 5.5%        | 8.9%        | 11.3%       |

### Earnings Per Share
| Metric                        | Q3 2025   | Q2 2025   | Q3 2024   | TTM         | 12/31/2024  | 12/31/2023  |
|-------------------------------|-----------|-----------|-----------|-------------|-------------|-------------|
| **Diluted EPS (GAAP)**        | $(2.77)   | $0.34     | $1.75     | $0.78       | $4.15       | $6.46       |
| **Diluted EPS (Ex. Items)**   | $1.01     | $0.62     | $1.91     | $1.96       | $4.15       | $6.46       |
| **Basic EPS**                 | $(2.77)   | $0.34     | $1.75     | $0.78       | $4.16       | $6.48       |
| **Weighted Avg Shares**       | 322M      | 322M      | 326M      | 324.5M      | 326M        | 326M        |

### Cash Flow & Liquidity
| Metric                        | Q3 2025   | Q2 2025   | Q3 2024   | TTM         | 12/31/2024  | 12/31/2023  |
|-------------------------------|-----------|-----------|-----------|-------------|-------------|-------------|
| **Operating Cash Flow**       | $983M     | $35M      | --        | $2,357M     | $3,819M     | $4,942M     |
| **Free Cash Flow**            | $463M     | --        | --        | $463M       | $1,980M     | $3,411M     |
| **Capital Expenditure**       | $406M     | --        | --        | $1,894M     | $1,839M     | $1,531M     |
| **Cash Conversion**           | 135%      | --        | --        | 99%         | --          | --          |
| **Cash & Equivalents**        | $1,801M   | $1,700M   | --        | --          | $3,388M     | $3,405M     |
| **Total Liquidity**           | $6,451M   | $6,350M   | --        | --          | --          | --          |

### Balance Sheet Health
| Metric                        | 9/30/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|-------------------------------|-----------|------------|------------|------------|------------|
| **Total Assets**              | --        | $35,746M   | $37,000M   | $36,365M   | $36,742M   |
| **Cash & Equivalents**        | $1,801M   | $3,388M    | $3,405M    | $2,156M    | $1,477M    |
| **Total Debt**                | $12,923M | $12,923M   | $13,001M   | $13,175M   | $13,599M   |
| **Net Debt**                  | $7,774M   | $7,774M    | $7,842M    | $9,170M    | $10,142M   |
| **Net Debt/EBITDA**           | 3.6x      | 2.2x       | 1.7x       | 1.4x       | 1.2x       |
| **Working Capital**           | --        | $5,561M    | $6,002M    | $5,085M    | $4,987M    |
| **Current Ratio**             | --        | 1.83       | 1.84       | 1.75       | 1.69       |
| **Shareholders' Equity**      | --        | $12,462M   | $12,930M   | $12,615M   | $11,858M   |

---

## Segment Performance Analysis

### Q3 2025 Segment EBITDA (Excluding Identified Items)
| Segment                           | Q3 2025 | Q2 2025 | Q3 2024 | Sequential Change |
|-----------------------------------|---------|---------|---------|-------------------|
| **Olefins & Polyolefins Americas** | $428M   | $313M   | $758M   | +$115M (+37%)      |
| **Olefins & Polyolefins EAI**     | $48M    | $(381)M | $81M    | +$429M             |
| **Intermediates & Derivatives**   | $290M   | $286M   | $317M   | +$4M (+1%)         |
| **Advanced Polymer Solutions**    | $47M    | $32M    | $19M    | +$15M (+47%)       |
| **Technology**                    | $34M    | $33M    | $69M    | +$1M (+3%)         |
| **Total EBITDA (Ex. Items)**      | $835M   | $715M   | $1,205M | +$120M (+17%)      |

### Segment Highlights

**Olefins & Polyolefins Americas:**
- Strong sequential improvement driven by Channelview restart and higher volumes
- Improved olefins margins with higher co-product contributions
- Polyethylene spreads decreased as monomer costs rose
- Operating rates targeted at 80% for Q4 2025
- Hyperzone PE plant showing improved performance

**Olefins & Polyolefins Europe, Asia & International:**
- Improved operations offset margin pressures
- $411M goodwill impairment in Q3 2025 (non-cash)
- European asset sale progressing with regulatory approvals
- Wesseling cracker to be idled in November for maintenance
- Operating rates targeted at 60% for Q4 2025

**Intermediates & Derivatives:**
- Oxyfuels benefited from improved octane margins and lower butane costs
- Styrene margins normalized as global supply recovered
- La Porte acetyls turnaround beginning in September
- Channelview PO/SM unit to be idled in November
- Operating rates targeted at 75% for Q4 2025

**Advanced Polymer Solutions:**
- $782M goodwill impairment in Q3 2025 (non-cash)
- 40% YTD EBITDA improvement excluding identified items
- 75% increase in Net Promoter Score from customers vs 2023
- Pricing pressure persists but cost reductions offsetting impact

**Technology:**
- Low licensing activity reflecting slowdown in global capacity additions
- Catalyst volumes improved but margins declined
- Expected to remain flat in Q4 2025

---

## Cash Flow Analysis

### Operating Cash Flow Trends
- **Q3 2025:** $983M with exceptional 135% cash conversion
- **TTM:** $2,357M operating cash flow
- **Cash Conversion:** 99% TTM (above through-cycle target of 80%)
- **Working Capital:** Managing working capital efficiently through cycle

### Capital Allocation
- **Capital Expenditures:** $406M in Q3 2025, guided to $1.2B for 2026 (down from $1.7B in 2025)
- **Dividends:** $443M returned to shareholders in Q3 2025
- **Share Buybacks:** Minimal in 2025-2026; focus on preserving cash
- **Debt Management:** Net debt issuance of $498M TTM; manageable debt maturity profile

### Cash Improvement Plan Progress
- **2025 Target:** $600M incremental cash flow
- **2026 Target:** Minimum $1.1B cumulative improvement
- **Components:**
  - Working capital optimization: $200M+
  - Fixed cost reductions: $150M YTD, targeting $200M+ annual run rate
  - CAPEX reduction: $300M reduction in 2026 from 2025 levels

---

## Balance Sheet Analysis

### Strengths
1. **Strong Liquidity:** $6.5B total liquidity provides significant financial flexibility
2. **Investment-Grade Rating:** Maintained despite cyclical downturn
3. **Manageable Debt:** Net debt/EBITDA of 3.6x (ex. identified items) is elevated but manageable
4. **Cash Position:** $1.8B cash provides cushion for cycle navigation

### Areas of Focus
1. **Debt Levels:** Total debt $12.9B with net debt of $7.8B
2. **Equity Declines:** Goodwill impairments reducing equity base
3. **Working Capital:** Managing working capital efficiently but subject to cycle volatility

---

## Key Financial Ratios

### Valuation Metrics (Current)
| Metric                    | Value      | Period         |
|--------------------------|------------|----------------|
| Market Cap               | $15.87B    | 11/03/2025     |
| Enterprise Value         | $27.40B    | 11/03/2025     |
| Trailing P/E             | 104.96     | TTM            |
| Forward P/E              | 12.99      | Forward        |
| Price/Sales              | 0.41       | TTM            |
| Price/Book               | 1.33       | MRQ            |
| EV/EBITDA (Ex. Items)    | 12.9x      | TTM            |
| EV/Revenue               | 0.71       | TTM            |

### Profitability Ratios
| Metric                    | Value      | Period         |
|--------------------------|------------|----------------|
| Gross Margin              | 8.7%       | TTM            |
| Operating Margin          | 4.0%       | TTM            |
| EBITDA Margin (Ex. Items) | 5.5%       | TTM            |
| Net Margin (Ex. Items)    | 1.7%       | TTM            |
| ROE (Ex. Items)           | --         | --             |
| ROIC (Ex. Items)          | --         | --             |

---

## Financial Health Assessment

### Strengths
1. **Strong Cash Generation:** Exceptional cash conversion even in downturn
2. **Liquidity Position:** $6.5B total liquidity provides significant buffer
3. **Investment-Grade Balance Sheet:** Maintained despite cyclical pressures
4. **Disciplined Capital Allocation:** Balancing shareholder returns with preservation
5. **Operational Discipline:** Cash Improvement Plan execution on track

### Concerns
1. **Cyclical Downturn:** Longest downturn in management's 35-year experience
2. **Margin Compression:** EBITDA margins down significantly from peak levels
3. **Asset Impairments:** $1.2B in Q3 write-downs reflect portfolio repositioning
4. **Revenue Decline:** TTM revenue down 4.1% from prior year
5. **Debt Levels:** Elevated net debt/EBITDA ratio during trough

---

## Forward Guidance & Outlook

### Q4 2025 Outlook
- **Year-end seasonality:** Expected to pressure results across most businesses
- **Operating Rates:** 
  - North American O&P: 80%
  - European O&P: 60%
  - Intermediates & Derivatives: 75%
- **Margin Pressures:** Higher feedstock costs expected in North America
- **Planned Maintenance:** Wesseling cracker and Channelview PO/SM idled for ~40 days

### 2025-2026 Financial Targets
- **Cash Improvement Plan:** $600M incremental cash flow in 2025, $1.1B by end of 2026
- **Capital Expenditures:** $1.7B in 2025, reduced to $1.2B in 2026
- **Portfolio Transformation:** European asset sale progressing
- **Sustainability:** MoReTec-1 construction ongoing in Germany

---

## Key Takeaways

1. **Operational Resilience:** Despite GAAP loss, underlying operations generating $835M EBITDA excluding identified items
2. **Cash Discipline:** Strong cash conversion and disciplined capital allocation preserving financial flexibility
3. **Strategic Positioning:** Portfolio repositioning toward cost-advantaged regions progressing
4. **Cycle Management:** Longest downturn in decades, but company maintaining financial discipline
5. **Valuation:** Trading at deep cyclical trough multiples (0.41x Price/Sales)

---

## Related Documents
- [Balance Sheet Analysis](../financials/2025_11/balance_sheet.md)
- [Cash Flow Analysis](../financials/2025_11/cashflow.md)
- [Income Statement](../financials/2025_11/income_statement.md)
- [Q3 2025 Press Release](../quarterly/2025_Q3_press_release.txt)
- [Q3 2025 Presentation](../quarterly/2025_Q3_presentation.txt)

*Analysis completed November 3, 2025. All financial data from company filings and presentations.*
